ATRA logo

ATRA
Atara Biotherapeutics Inc

3,771
Mkt Cap
$43.84M
Volume
43.39M
52W High
$19.15
52W Low
$3.92
PE Ratio
1.77
ATRA Fundamentals
Price
$9.89
Prev Close
$5.15
Open
$7.86
50D MA
$5.15
Beta
2.24
Avg. Volume
64,042.83
EPS (Annual)
$2.57
P/B
-0.98
Rev/Employee
$8.63M
$274.38
Loading...
Loading...
News
all
press releases
ATRA Stock Sees Biggest Single-Day Gain In Over 2 Years, Breaches Key Technical Milestone – New FDA Update Has Bulls Circling Back
Atara said it made progress with the FDA on a potential path to resubmitting the biologics license application for its immunotherapy Tabelecleucel.
Stocktwits·2h ago
News Placeholder
More News
News Placeholder
Healthcare Disruption, AI Biologics, and Wall Street Upgrades Ignite a Midday Market Surge
Healthcare innovators are pushing the markets today. $TGNT, $AGL, $ATRA, $ASBP
24-7 Market News·3h ago
News Placeholder
Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients...
Business Wire·4h ago
News Placeholder
Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to...
PR Newswire·2d ago
News Placeholder
The Gross Law Firm Reminds Atara Biotherapeutics, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of May 22, 2026 - ATRA
The Gross Law Firm Reminds Atara Biotherapeutics, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of May 22, 2026 - ATRA The Gross Law Firm Reminds Atara...
PR Newswire·2d ago
News Placeholder
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit PR Newswire...
PR Newswire·6d ago
News Placeholder
ATRA SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026
ATRA SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 ATRA SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP...
PR Newswire·6d ago
News Placeholder
Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA
Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA Pomerantz Law Firm Announces the Filing of a Class Action Against Atara...
PR Newswire·7d ago
News Placeholder
Lost Money on Atara Biotherapeutics, Inc.(ATRA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Lost Money on Atara Biotherapeutics, Inc.(ATRA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky Lost Money on Atara Biotherapeutics, Inc.(ATRA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky PR Newswire NEW YORK, April 29, 2026 NEW YORK, April 29, 2026...
PR Newswire·8d ago
News Placeholder
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRA
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRA The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline...
PR Newswire·9d ago
<
1
2
...
>

Latest ATRA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.